Market Insights
Independent, authoritative news, and market research insights for pharmaceutical and medical device professionals.
Independent, authoritative news, and market research insights for pharmaceutical and medical device professionals.
High stakes are a given in the pharmaceutical development business. So is high risk. The only thing that can mitigate those threats is intelligence—insights and hard data on threatening or promising trends and industry best practices,
That’s why WCG’s Market Insights Division delivers the drug industry’s most incisive, wide-ranging news and intelligence on clinical trials and regulatory compliance.
Our intelligence services cover new actions by the FDA, EMA and other regulatory agencies, as well as clinical trial performance standards and benchmarks, so you can make smarter strategic decisions.
Clinical operations, development, quality assurance, and regulatory affairs professionals in the pharmaceutical and medical device industries use four WCG intelligence sources to reduce risk, delays, and surprises. They ensure you have the right data at the right time at the right cost.
CenterWatch / Clinical Trials Tracking
WCG’s CenterWatch provides executives the leading source of clinical trial progress and results globally to ensure superior performance of your own studies—ensuring that they proceed faster, smoother, and at a lower cost. Our newsletters, Research Center Profiles, market analytics services, drug approvals database, webinars and white papers make WCG’s CenterWatch your first call for tracking clinical trials.
Visit Centerwatch.com
FDAnews / Regulatory Compliance Intelligence
WCG’s FDAnews gives regulatory and quality executives the most thorough, up-to-date understanding of inner workings at the FDA and EMA and how they’re likely to alter your development and manufacturing strategies. If you’re looking to ensure successful regulatory inspections and audits, you’ll value our 483s database, eLearning, webinars and conferences on manufacturing quality assurance, compliance and risk mitigation.
Visit FDANews.com